These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9566408)

  • 41. Identification of Spanish familial Parkinson's disease and screening for the Ala53Thr mutation of the alpha-synuclein gene in early onset patients.
    Muñoz E; Oliva R; Obach V; Martí MJ; Pastor P; Ballesta F; Tolosa E
    Neurosci Lett; 1997 Oct; 235(1-2):57-60. PubMed ID: 9389595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Drosophila model of Parkinson's disease.
    Feany MB; Bender WW
    Nature; 2000 Mar; 404(6776):394-8. PubMed ID: 10746727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parkinson's disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons.
    Saha AR; Hill J; Utton MA; Asuni AA; Ackerley S; Grierson AJ; Miller CC; Davies AM; Buchman VL; Anderton BH; Hanger DP
    J Cell Sci; 2004 Mar; 117(Pt 7):1017-24. PubMed ID: 14996933
    [TBL] [Abstract][Full Text] [Related]  

  • 44. No mutation in the entire coding region of the alpha-synuclein gene in pathologically confirmed cases of multiple system atrophy.
    Ozawa T; Takano H; Onodera O; Kobayashi H; Ikeuchi T; Koide R; Okuizumi K; Shimohata T; Wakabayashi K; Takahashi H; Tsuji S
    Neurosci Lett; 1999 Jul; 270(2):110-2. PubMed ID: 10462110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the gamma-synuclein gene in German Parkinson's disease patients.
    Krüger R; Schöls L; Müller T; Kuhn W; Woitalla D; Przuntek H; Epplen JT; Riess O
    Neurosci Lett; 2001 Sep; 310(2-3):191-3. PubMed ID: 11585599
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.
    Krüger R; Kuhn W; Müller T; Woitalla D; Graeber M; Kösel S; Przuntek H; Epplen JT; Schöls L; Riess O
    Nat Genet; 1998 Feb; 18(2):106-8. PubMed ID: 9462735
    [No Abstract]   [Full Text] [Related]  

  • 47. Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants.
    Conway KA; Lee SJ; Rochet JC; Ding TT; Harper JD; Williamson RE; Lansbury PT
    Ann N Y Acad Sci; 2000; 920():42-5. PubMed ID: 11193175
    [No Abstract]   [Full Text] [Related]  

  • 48. Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype.
    Khan N; Graham E; Dixon P; Morris C; Mander A; Clayton D; Vaughan J; Quinn N; Lees A; Daniel S; Wood N; de Silva R
    Ann Neurol; 2001 May; 49(5):665-8. PubMed ID: 11357958
    [TBL] [Abstract][Full Text] [Related]  

  • 49. No mutation of G209A in the alpha-synuclein gene in sporadic Parkinson's disease among Taiwan Chinese.
    Hu CJ; Sung SM; Liu H; Chang JG
    Eur Neurol; 1999; 41(2):85-7. PubMed ID: 10023110
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Absence of the G209A mutation in the alpha-synuclein gene in British families with Parkinson's disease.
    Bennett P; Nicholl DJ
    Neurology; 1998 Apr; 50(4):1183. PubMed ID: 9566424
    [No Abstract]   [Full Text] [Related]  

  • 51. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.
    Lee MK; Stirling W; Xu Y; Xu X; Qui D; Mandir AS; Dawson TM; Copeland NG; Jenkins NA; Price DL
    Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8968-73. PubMed ID: 12084935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation.
    Narhi L; Wood SJ; Steavenson S; Jiang Y; Wu GM; Anafi D; Kaufman SA; Martin F; Sitney K; Denis P; Louis JC; Wypych J; Biere AL; Citron M
    J Biol Chem; 1999 Apr; 274(14):9843-6. PubMed ID: 10092675
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
    Conway KA; Harper JD; Lansbury PT
    Nat Med; 1998 Nov; 4(11):1318-20. PubMed ID: 9809558
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations.
    McLean PJ; Kawamata H; Ribich S; Hyman BT
    J Biol Chem; 2000 Mar; 275(12):8812-6. PubMed ID: 10722726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
    Corti O; Brice A
    Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Genetics and environmental factors of Parkinson disease].
    Broussolle E; Thobois S
    Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S11-23. PubMed ID: 12690660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Parkinson's disease and other alpha-synucleinopathies.
    Goedert M
    Clin Chem Lab Med; 2001 Apr; 39(4):308-12. PubMed ID: 11388653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. alpha-Synuclein gene and Parkinson's disease. The French Parkinson's Disease Study Group.
    Science; 1998 Feb; 279(5354):1116-7. PubMed ID: 9508681
    [No Abstract]   [Full Text] [Related]  

  • 59. Interaction of alpha-synuclein and synphilin-1: effect of Parkinson's disease-associated mutations.
    Kawamata H; McLean PJ; Sharma N; Hyman BT
    J Neurochem; 2001 May; 77(3):929-34. PubMed ID: 11331421
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetics of Parkinson's disease.
    Gasser T
    Ann Neurol; 1998 Sep; 44(3 Suppl 1):S53-7. PubMed ID: 9749573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.